Last Updated: May 26, 2023, 05:15 IST
Washington D.C., United States of America (USA)
Neuralink logo and Elon Musk photo are seen in this illustration taken, December 19, 2022. (Reuters/Dado Ruvic/Illustration)
Neuralink said clearance from the US Food and Drug Administration for its first in-human clinical study is “an important first step” for its technology
Elon Musk’s start-up Neuralink on Thursday said it has gotten approval from US regulators to test its brain implants in people.
Neuralink said clearance from the US Food and Drug Administration for its first in-human clinical study is “an important first step” for its technology, which is intended to let brains interface directly with computers.
(This story has not been edited by News18 staff and is published from a syndicated news agency feed – AFP)
